Aerovate Therapeutics Total Assets 1970-1969 | AVTE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Aerovate Therapeutics total assets from 1970 to 1969. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Aerovate Therapeutics total assets from 1970 to 1969. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$226.4B
Amgen (AMGN)	$166.3B
Gilead Sciences (GILD)	$141.3B
Vertex Pharmaceuticals (VRTX)	$122.5B
Bristol Myers Squibb (BMY)	$99.7B
CSL (CSLLY)	$85.2B
GSK (GSK)	$77.9B
Regeneron Pharmaceuticals (REGN)	$61.8B
Alnylam Pharmaceuticals (ALNY)	$42.5B
Argenex SE (ARGX)	$35.2B
BioNTech SE (BNTX)	$27.5B
Royalty Pharma (RPRX)	$20.2B
Insmed (INSM)	$19.6B
Biogen (BIIB)	$19.2B
Illumina (ILMN)	$16.6B
Genmab (GNMSF)	$14.9B
Genmab (GMAB)	$14.7B
Incyte (INCY)	$13.7B
Moderna (MRNA)	$13.4B
Exelixis (EXEL)	$12.4B
BioMarin Pharmaceutical (BMRN)	$11.4B
QIAGEN (QGEN)	$11.2B
Swedish Orphan Biovitrum (BIOVF)	$10.6B
Ascendis Pharma (ASND)	$10.4B
Exact Sciences (EXAS)	$9.1B
Verona Pharma American Depositary Share (VRNA)	$8.9B
Bio-Techne Corp (TECH)	$8.7B
Blueprint Medicines (BPMC)	$8.3B
Legend Biotech (LEGN)	$8.1B
Roivant Sciences (ROIV)	$7.7B